Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.


OBJECTIVE Because microRNA-145 (miR-145) is a specific mediator in the regulation of the proliferation and differentiation of smooth muscle cells, we investigated the effect of miR-145 on the intimal hyperplasia in the rabbit model of vein graft disease using electroporation-mediated gene transfer. METHODS The right jugular vein of male Japanese white rabbits was harvested and transduced with miR-145-encoding plasmids using an electroporator and then interposed in the carotid artery. At 2 or 4 weeks postoperatively, the venous graft was explanted, and the intimal thickness and intima/media area ratio were evaluated. Furthermore, 3 days after implantation, the myocardin and serum response factors were measured using real-time polymerase chain reaction. At 2 weeks after implantation, immunohistochemical investigations using mature smooth muscle markers, myosin heavy chain smooth muscle-1 and -2, and proliferation marker Ki-67 were performed. RESULTS MiR-145 transduction significantly reduced the neointimal thickness at both 2 and 4 weeks (2 weeks, 52.1 ± 15.7 vs 113.2 ± 26.9 μm, P < .05, n = 6; 4 weeks, 42.4 ± 4.8 vs 136.5 ± 38.3 μm, P < .05, n = 8), and it also significantly reduced the intima/media area ratio at 4 weeks (0.22 ± 0.04 vs 1.13 ± 0.23, P < .01, n = 8). Additionally, it upregulated the mRNA expression level of myocardin compared with that in the grafts that did not receive gene transfer. Smooth muscle-2 and Ki-67 expression revealed that miR-145 transduced grafts contained more smooth muscle-2-positive mature smooth muscle cells and fewer Ki-67-positive proliferating cells. CONCLUSIONS Nonviral transduction of miR-145 into the bypass graft could be a novel option for preventing intimal hyperplasia in vein graft disease.

DOI: 10.1016/j.jtcvs.2013.11.054

5 Figures and Tables

Citations per Year

Citation Velocity: 12

Averaging 12 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Ohnaka2014EffectOM, title={Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.}, author={Motoaki Ohnaka and Akira Marui and Kenichi Yamahara and Kenji Minakata and Kazuhiro Yamazaki and Motoyuki Kumagai and Hidetoshi Masumoto and Shiro Tanaka and Tadashi Ikeda and Ryuzo Sakata}, journal={The Journal of thoracic and cardiovascular surgery}, year={2014}, volume={148 2}, pages={676-82.e2} }